Precision Health Diagnostics Ltd. is a private limited liability company (GHS) that will establish a full‑service diagnostic laboratory and medical imaging centre on Lagos Avenue in East Legon, Accra. The facility brings together haematology, clinical chemistry, microbiology, digital X‑ray, ultrasound, CT scanning, and a digital patient portal under one roof, all anchored by a same‑day results guarantee. This plan presents the market case, operational framework, and financial projections that demonstrate robust profitability, strong cash generation, and an attractive return for investors.
Executive Summary
Precision Health Diagnostics Ltd. closes a widening gap in Accra’s private healthcare ecosystem. Middle‑ and upper‑income professionals, expatriate families, corporate executives, and referring physicians in the East Legon–Airport Residential–Spintex corridor routinely face a trade‑off: overcrowded public hospital labs that deliver reports days or weeks late, or premium overseas‑style facilities that charge steep premiums and still rarely offer one‑stop testing. Precision Health Diagnostics resolves that tension by positioning a comprehensive, digitally enabled diagnostic hub that guarantees same‑day results for 90% of routine investigations and wraps the entire experience in an online booking‑to‑WhatsApp‑report journey.
The centre will operate from a 180‑square‑metre leased space on Lagos Avenue, East Legon—a prime commercial‑residential artery that feeds a daytime and residential catchment of over 500,000 people. The legal vehicle is a private company limited by shares, already registered with the Registrar General’s Department, with the Health Facility Regulatory Agency (HeFRA) licence in its final stage. The founders have injected GHS 900,000 in equity, and the business seeks a five‑year term loan of GHS 1,300,000, bringing total capital to GHS 2,200,000. Those funds cover every piece of diagnostic equipment, the clinic fit‑out, initial inventory, a six‑month working‑capital cushion, and a controlled contingency.
The service menu is priced transparently, with an expected weighted average of GHS 200 per patient visit. Year‑1 patient volume is projected at 12,600 visits, yielding gross revenue of GHS 2,520,000. Direct cost of sales—reagents, consumables, contrast media—runs at exactly 25% of revenue, producing a gross margin of 75%. Fixed monthly operating costs, including salaries for seven staff, rent, utilities, marketing, insurance, and equipment maintenance, total GHS 60,000 per month (GHS 720,000 per annum). Because the business surpasses break‑even in its first month of operation and finishes Year 1 with a net income of GHS 524,250, the model generates a net margin of 20.8% and an EBITDA margin of 46.4%. By Year 5, annual revenue reaches GHS 6,506,321 and net income climbs to GHS 2,688,891, a margin of 41.3%.
The founding team is led by Funmi Ncube, an MD in Laboratory Medicine who most recently served as Head of Pathology at a 120‑bed private hospital in Tema. She is joined by Morgan Kim (Operations), Avery Singh (Chief Radiographer), Sam Patel (Finance), and Drew Martinez (Marketing)—a group whose clinical, operational, and financial credentials give investors confidence in execution. This plan demonstrates that Precision Health Diagnostics is not merely a laboratory but a high‑margin, scalable platform that answers a clear and growing need. The combination of strong unit economics, a proven market, and a management team with deep healthcare experience makes this an investment‑grade opportunity.
Company Description
Business Identity and Legal Foundation
The business operates under the registered name Precision Health Diagnostics Ltd. It is a private limited liability company incorporated under the Companies Act of Ghana, with the certificate issued by the Registrar General’s Department. The choice of a limited liability structure serves multiple purposes: it shields the personal assets of the shareholders, it signals credibility to institutional lenders, insurers, and corporate clients, and it facilitates the admission of minority investors when the business enters its expansion phase. The company’s registered office is the same as its operational address—Lagos Avenue, East Legon, Accra—ensuring that all statutory filings, HeFRA inspections, and commercial correspondence radiate from a single, visible location.
Location and Strategic Rationale
East Legon is one of Accra’s most affluent suburbs, characterized by a mix of high‑end residences, diplomatic enclaves, corporate headquarters, and private medical clinics. Lagos Avenue itself connects the main thoroughfares of the Spintex Road and the Airport Residential Area, giving the centre direct vehicular access from three of the city’s highest‑income neighbourhoods. The site sits within a dense cluster of private general practitioners, specialist dental and eye clinics, and pharmacies—all of which are natural referral sources that currently send patients to laboratories 10 kilometres or more away. The 180‑square‑metre unit is configured to accommodate separate laboratory, imaging, reception, waiting, and administrative zones, with room to add a dedicated stress‑ECG and echo bay in Year 2 without requiring structural alteration. The landlord has granted a ten‑year lease with a fixed escalation of 8% every two years, which is already built into the financial projections through the rent line item that starts at GHS 12,000 per month and grows to GHS 23,128 by Year 5, part of the GHS 277,540 total rent and utilities expense in that year.
Mission, Vision, and Core Values
The mission is straightforward: to provide West Africa’s most reliable, rapid, and accessible diagnostic service by combining modern technology with a culture of clinical excellence and patient respect. The vision extends beyond a single centre—the company intends to become Ghana’s most trusted diagnostic network, operating multiple full‑service centres and satellite collection points by the end of Year 5, servicing over 25,000 patient visits annually. Three core values guide every operational decision: accuracy (every result is verified by two‑level quality control), speed (90% of routine results are delivered within four hours), and transparency (patients see their prices before they book, and reports are sent directly to their phones without hidden charges).
Ownership and Governance
The initial equity of GHS 900,000 is provided by Funmi Ncube from personal savings and a family investment pool, giving her 100% ownership at launch. A three‑member board of directors will be constituted before the centre opens, comprising Funmi Ncube as Managing Director, an independent non‑executive director with a background in healthcare regulation, and a representative of a future strategic investor should the company choose to raise a Series‑A round in Year 3. This governance structure satisfies Ghana’s company law requirements and reassures debt providers that oversight is in place. All directors will act under a formal board charter that mandates quarterly financial reporting and annual external audits by a registered firm of chartered accountants.
Licence and Regulatory Pathway
Precision Health Diagnostics has completed the first two stages of HeFRA certification: the site has been inspected for suitability, and the facility design meets the agency’s minimum standards for a combined laboratory and imaging centre. The final operating licence is expected within six weeks of the date of this plan. In parallel, the lab section is undergoing ISO 15189 pre‑accreditation through the Ghana Standards Authority, a process managed by Funmi Ncube and Avery Singh, who have experience in international laboratory accreditation from their previous roles. The imaging equipment—the digital X‑ray, ultrasound, and CT scanner—has already been type‑approved by the Ghana Atomic Energy Commission’s Radiation Protection Institute, and Avery Singh holds a valid licence as a radiation safety officer. Taken together, the regulatory stack ensures that the centre will open fully compliant, with no risk of enforcement stoppages.
Products / Services
Precision Health Diagnostics presents an integrated menu covering the three pillars of modern outpatient diagnostics: laboratory medicine, medical imaging, and digital health delivery. Every service is deliberately designed to be ordered individually or as part of a package, and the physical layout of the centre allows a patient to move from blood draw to ultrasound to X‑ray within the same 45‑minute visit.
Laboratory Medicine
The laboratory provides haematology, clinical chemistry, serology, and microbiology testing using analysers that have been selected for throughput, reliability, and low reagent cost. The haematology suite centres on a five‑part differential automated analyser (GHS 80,000) capable of running 60 samples per hour. The clinical chemistry bench uses a fully automated, random‑access platform (GHS 120,000) that handles the full menu expected in a private practice setting—lipid profiles (GHS 120), liver and renal function panels, HbA1c, cardiac troponin, and electrolyte panels. The microbiology area performs urine culture, sensitivity, and stool analysis in‑house, with specialised mycology samples sent to a reference laboratory under a negotiated service agreement that keeps turnaround under 72 hours.
A typical walk‑in patient seeking a full blood count pays GHS 80 and receives the result via WhatsApp three hours later. The same patient could add a fasting lipid profile for GHS 120, bringing the total to GHS 200—exactly the projected weighted average revenue per visit. For patients requiring regular monitoring, such as those on warfarin (INR) or immunosuppressant therapy (drug‑level assays), the lab offers a subscription plan: a monthly fee of GHS 150 covers up to three blood draws and all associated reports, with automatic reminders. This plan locks in recurring revenue and improves patient adherence.
Medical Imaging
The imaging division operates three modalities under one roof, a configuration rarely found outside Ghana’s few large private hospitals.
- Digital X‑ray (GHS 150): A ceiling‑mounted digital radiography (DR) system with a flat‑panel detector captures chest, skeletal, and soft‑tissue images with 90‑second processing. The machine’s low radiation dose protocol makes it suitable for paediatric use and repeat examinations. Avery Singh, the Chief Radiographer, has written standard operating procedures that align with the Royal College of Radiologists’ guidelines.
- Ultrasound (GHS 200–400): A mid‑range colour Doppler ultrasound system (GHS 150,000) provides abdominal, pelvic, obstetric, thyroid, and breast scans, as well as vascular studies. The price of GHS 200 for a basic abdominal scan is 25% below the median private‑sector rate in Accra, a deliberate strategy to attract price‑sensitive corporate wellness contracts.
- CT Scan (GHS 600–1,200): The centre’s refurbished 16‑slice CT scanner (GHS 600,000) handles head, chest, abdomen, pelvis, and spine imaging without contrast. Contrast‑enhanced studies command a GHS 1,200 fee, covering the cost of iodinated contrast and the extra nursing supervision. All scans are read by a teleradiology partner in South Africa—a board‑certified radiologist who provides a structured report within 12 hours, fully indemnified. This model obviates the need for a full‑time on‑site radiologist in the early years and keeps the cost base lean.
Digital Patient Experience and Health IT
The clinical output is wrapped in a digital experience that matches what Ghanaian professionals expect from their banks and mobile networks. The laboratory information system (LIS), radiology information system (RIS), and picture archiving and communications system (PACS) were procured as an integrated suite at a cost of GHS 50,000. The system enables:
- Online booking: Patients select an appointment slot, choose the required tests, and see an exact price before confirming. The calendar syncs with the receptionist’s screen, preventing double‑booking.
- Sample tracking: Barcoded vials link each specimen to the patient’s electronic record, eliminating transcription errors.
- Auto‑validation and release: When a result falls within a pre‑set normal range, the LIS auto‑validates it and pushes a secure PDF to the patient’s WhatsApp number. Abnormal results are flagged to the lab technologist and the referring doctor simultaneously through the portal.
- Referring physician portal: A free, password‑protected dashboard displays all results ordered by that clinic, complete with trend graphs. The portal removes the need for fax or paper delivery and is the key incentive offered to the 50 clinics visited during the referral‑network launch.
Packages and Corporate Wellness
Four pre‑priced screening packages, ranging from GHS 400 to GHS 2,500 per employee, are tailored for corporate HR managers:
- Basic (GHS 400): FBC, urinalysis, malaria RDT, blood pressure check, vision test.
- Advanced (GHS 1,200): Adds lipid profile, fasting glucose, creatinine, and abdominal ultrasound.
- Executive (GHS 2,500): A full work‑up including CT chest, stress ECG (to be introduced Year 2), liver and kidney panels, and a consultation with a visiting physician.
- Custom packages: Corporates can mix modules; a bank, for instance, may add a prostate‑specific antigen (PSA) test for all male employees over 40.
The pricing for all services and packages is set in Ghana Cedi and reviewed annually against inflation and competitor benchmarks. Revenue projections use the weighted average of GHS 200 per visit for the walk‑in mix and an uplift of approximately 15% for corporate package visits, a dynamic already captured in the Year 2 onward revenue growth rates of 19.1% and 29.4% as the corporate book expands.
Market Analysis
Macro‑Health Context in Ghana
Ghana’s healthcare spending has grown at a compound rate of over 12% annually since the introduction of the National Health Insurance Scheme (NHIS), yet the country still contends with an epidemiological double burden: infectious diseases such as malaria, typhoid, and hepatitis on one side, and a rapid rise in non‑communicable diseases (NCDs) like hypertension, diabetes, and cancer on the other. The World Health Organization estimates that NCDs now account for 43% of all deaths in Ghana, and early diagnosis is the single most cost‑effective lever to reduce that toll. Diagnosis, however, depends on reliable laboratory and imaging infrastructure, which remains concentrated in Accra and Kumasi and is overwhelmingly public. The private sector has responded with standalone labs and a few high‑end imaging centres, but fragmentation forces patients to travel to multiple locations, often waiting days for paper reports. This structural inefficiency creates the demand that Precision Health Diagnostics is built to capture.
Target Market Definition
The core catchment is defined as all residential and working populations within a 5‑kilometre radius of the East Legon site. That radius covers the Airport Residential Area, Cantonments, Roman Ridge, Spintex Road from Papaye to the Tema Motorway junction, and the western edge of Madina. Using ward‑level projections from the Ghana Statistical Service’s 2021 population census, updated with an annual growth assumption of 2.1%, the resident population within that ring exceeds 350,000. Adding the daytime workforce—employees of the international airlines along the Spintex corridor, the banks headquartered on Airport Boulevard, the embassies in Cantonments, and the staff of the Kotoka International Airport—swells the daytime catchment to over 500,000 adults aged 20 to 60.
Market sizing then narrows to those who can afford private diagnostics. A 2022 Afrobarometer survey indicated that 34% of urban Ghanaians report being able to pay for private healthcare without selling assets or borrowing. Applying that factor yields approximately 170,000 economically capable adults. Conservative end‑user research conducted with twelve private clinic owners in the catchment suggests that this segment seeks at least one diagnostic episode per year—often a routine annual medical, a doctor‑ordered lab panel, or a screening ultrasound. This translates to roughly 170,000 patient episodes annually in the immediate zone. For added prudence, the plan uses a smaller figure of 200,000 potential episodes derived from the clinic‑owner conversations, two‑thirds of which are returning patients. Capturing just 6% of that volume fills the first‑year capacity of 12,600 visits, leaving substantial headroom for growth without relying on tourists or patients from outside Accra.
Patient Segments and Psychographics
- Busy professionals (35% of visits): Men and women aged 28–50 who work in banking, oil and gas, telecoms, or diplomacy. They value speed above all else: a one‑hour wait can derail a morning of meetings. They are digitally fluent, prefer WhatsApp communication, and will happily pay a premium of 10–15% for a guaranteed 4‑hour turnaround.
- Health‑conscious families (25%): Parents who schedule regular check‑ups for themselves and their children. They respond to bundling and subscription offers and are frequent sharers of positive experiences on neighbourhood WhatsApp groups. Word‑of‑mouth in this segment, once ignited, acts as a free marketing engine.
- Corporate HR departments (20%): Decision‑makers at mid‑sized companies (50–300 employees) who need pre‑employment medicals, annual wellness screens, and executive health checks. Their purchasing decision is driven by package price transparency, digital reporting to reduce administrative burden, and the ability to deliver group‑level anonymised health trend data.
- Referring private practitioners (15%): General practitioners and specialist clinics in the catchment who lack in‑house diagnostics. They require a partner that can receive a patient sample in the morning, return a verified result before the clinic’s afternoon session, and never poach the patient.
- Expatriates and diplomatic staff (5%): Individuals with international health insurance who demand a facility that meets ISO standards and can furnish reports in English with calibrated reference ranges. This segment is small but high‑margin and generates foreign currency income when patients pay directly.
Competitor Analysis
Three incumbents define the competitive landscape, each with a distinct weakness that Precision Health Diagnostics exploits.
MDS Lancet Laboratories (Labone branch). Lancet is the region’s largest laboratory network, and its Labone facility draws patients from East Legon. The brand is trusted, but patients report two consistent frustrations: a 48‑hour turnaround for many routine tests (lipids and chemistry often go to the central hub in South Africa), and no on‑site imaging. A patient who needs both an ultrasound and a blood panel must drive to two different facilities. Precision Health Diagnostics targets this gap by offering the same menu in one location with 4‑hour reports.
Korle Bu Teaching Hospital’s diagnostics. Ghana’s premier public facility provides the broadest test menu at the lowest out‑of‑pocket cost, often covered by NHIS. However, the experience for a paying private patient is punishing: queues form before 5 a.m., radiology report delivery can stretch to five days, and the physical environment is overcrowded. The public‑system waiting time pushes time‑sensitive patients toward private solutions. Precision Health Diagnostics attracts them by cutting the wait from days to hours and offering a private, air‑conditioned waiting area.
Euracare Advanced Diagnostics (Spintex Road). Euracare has modern CT and MRI facilities and a strong reputation among medical tourists. Its prices, however, are positioned at the top decile—an abdominal CT can run to GHS 1,500—and its laboratory arm is underdeveloped. Euracare’s imaging model is built around scheduled appointments for high‑acuity cases, not high‑volume walk‑in lab work. Precision Health Diagnostics does not compete head‑to‑head on high‑end MRI; instead, it offers a CT scan at GHS 600 (40% less) and surrounds that imaging with a full lab menu, effectively funnelling Euracare’s more budget‑conscious imaging clients.
Other competitors. A handful of small, doctor‑owned labs exist along Spintex and in Madina. They offer limited menus (usually haematology and rapid tests only) and rely on a single technologist. Their quality and turnaround are inconsistent. By contrast, Precision Health Diagnostics offers a formal quality management system, dual‑head reporting for abnormal results, and a physical environment built from the ground up for diagnostics, not retrofitted into a consulting room.
Market Trends and Regulatory Tailwinds
- NHIS private‑provider expansion: Ghana’s NHIS is progressively accrediting private diagnostic centres to reduce referral pressure on Korle Bu and Komfo Anokye. Precision Health Diagnostics’ HeFRA licence and planned NHIS accreditation will make it an in‑network provider, giving it access to the scheme’s 12‑million‑member base, a portion of whom pay co‑pays for advanced imaging.
- Rise of telemedicine: Accra‑based telehealth platforms like Redbird and mPharma are growing rapidly, and every consultation that results in a test order needs a lab partner. Precision Health Diagnostics is building API integrations into its LIS to allow seamless result transfer, positioning itself as the lab of choice for digital clinics.
- Blue‑chip corporate wellness: Ghana’s labour regulations do not mandate annual medicals, but international companies and banks increasingly offer them as a retention benefit. The corporate wellness market in Accra is estimated at GHS 80–120 million annually and is underserved by quality‑focused providers who can produce digital boardroom reports. Precision Health Diagnostics’ executive packages are designed precisely for this growing segment.
Marketing & Sales Plan
The marketing strategy is engineered to convert a catchment of 500,000 into a loyal patient base of 1,300 monthly visits by Month 12, using a tiered mix of digital acquisition, direct referral network building, and community activation. The launch‑phase budget is GHS 30,000, followed by a sustained monthly spend that starts at GHS 5,000 and scales to GHS 6,803 by Year 5 (a component of the GHS 81,629 annual marketing line), ensuring that cost per acquisition never exceeds 12% of the lifetime value of a patient.
Brand Identity and Digital Presence
The brand “Precision Health Diagnostics” communicates exactly what the centre delivers. The visual identity—a stylised caduceus overlaid on a pulse waveform—will be applied consistently across the clinic fascia, staff uniforms, report templates, and digital assets. The website is a mobile‑first progressive web application that loads in under two seconds on a 3G connection, critical in a market where 80% of health‑related searches originate on smartphones. The site performs four functions: (1) a test price calculator where patients select their desired tests and immediately see the total cost, (2) an online booking engine tied to the LIS calendar, (3) a secure upload portal for referral forms, and (4) a blog section producing two 1,200‑word articles per month on topics such as “Understanding Your Lipid Profile” and “When to Get an Ultrasound”——all optimised for terms like “blood test near me East Legon” and “affordable CT scan in Accra”. The Google My Business (now Google Business Profile) listing will be optimised with 360° interior photos, a Q&A section answering the top 10 patient questions, and the “same‑day results” call‑out. Google Local Services Ads, set at a maximum cost‑per‑click of GHS 2.50, will run for six months to capture high‑intent search traffic, particularly during the 7–10 a.m. window when professionals schedule their day.
Social Media and Content Marketing
Instagram and Facebook carousel ads will showcase the facility’s clean, modern interiors, the smiling but professional staff, and the key value propositions: “Blood test at 8 a.m., result by noon,” with a screenshot of a WhatsApp report. A series of 15‑second patient‑testimonial videos (with signed consent) will be boosted to lookalike audiences built from the email lists of local pharmacies that partner in the referral programme. Drew Martinez, the Marketing Manager, will run a twice‑weekly health‑education Instagram Reel featuring a lab technologist explaining what a lipid profile measures or what a CT scan detects, with a call‑to‑action to book via the website. TikTok will be used for lighter content—a short clip showing a phlebotomist performing a painless draw, a time‑lapse of the lab processing samples. The combined social budget is 40% of the monthly marketing spend, with performance monitored through cost‑per‑booking tracked by UTM parameters.
Referral Network Activation
The single highest‑return activity in the first 90 days is Funmi Ncube’s personal outreach to 50 private clinics, pharmacies, and diagnostic corners within the catchment. Each visit follows a script that leaves behind a “starter pack” containing a doctor‑portal login, a printed menu with specimen‑transport guidelines, and a stack of patient referral cards. The referring doctor receives an ethical referral coordination fee of GHS 10 per compliant patient—a practice endorsed by the Ghana Medical and Dental Council’s 2021 advisory on private partnerships. More importantly, the portal gives the doctor a live view of the results, eliminating the phone‑call chase that characterises the current workflow. Once a clinic sees that a lipid profile taken at 9 a.m. lands in the portal at 12:30 p.m., the behaviour change is immediate. Precision Health Diagnostics targets 30 active referring clinics by the end of Month 3, a number that will grow to 60 by Year 2.
Corporate Health and Insurance Empanelment
The corporate sales outreach is led by Morgan Kim, who will present the three screening packages to HR managers at 20 mid‑sized firms in Airport Residential and Spintex during the pre‑launch quarter. The pitch deck includes a sample anonymised annual wellness report that shows aggregated trends (e.g., “42% of your workforce has elevated LDL cholesterol”), positioning the diagnostic centre as a strategic partner in workforce health. On the insurance side, the centre is completing empanelment with Metropolitan Life, Enterprise Insurance, and Glico Health. Once accredited, Precision Health Diagnostics becomes a network provider for their corporate plans, tapping into an insured population of over 300,000 in Greater Accra. The NHIS accreditation, which will be pursued as soon as HeFRA grants the operating licence, opens a further channel for co‑paid services, particularly imaging, where the NHIS tariff covers a portion and patients pay a pre‑determined top‑up.
Community Activation and Public Relations
On the last Saturday of every month, the clinic will set up a tent at the East Legon Farmers’ Market, offering free blood pressure and blood‑sugar checks. Two nurses and a doctor will be present; persons with abnormal readings will be given a QR‑code voucher that entitles them to a 20% discount on a full lipid profile and ECG at the centre within seven days. Drew Martinez tracks the conversion from free screening to paid visit, aiming for a 35% conversion rate—a figure derived from similar activation events run by the dental group he previously managed. Additionally, the company will sponsor the medical segment of Accra‑based radio station Citi FM’s morning show once a quarter, a high‑trust platform that reaches the car‑commuting professional audience.
Sales Funnel and Customer Retention
The marketing technology stack integrates a lightweight CRM (Zoho) that captures every lead from the website, social ads, and walk‑ins. A drip‑email sequence educates new patients about the patient portal, reminds them of repeat tests, and offers seasonal promotions (e.g., “Father’s Day Executive Package”). Retained patients who visit more than three times receive a loyalty card that accumulates points redeemable against future tests. Early‑stage customer data analysis will segment the patient base by frequency, spend, and referral source, allowing the marketing team to double down on the highest‑yield channels. By Year 3, the cost per acquisition should fall below GHS 30, and 40% of monthly visits will come from returning patients and direct word‑of‑mouth—indicators of a healthy brand.
Operations Plan
The operations design translates the same‑day‑results promise into a reliable, audit‑ready process. Every workflow—from patient registration to final report dispatch—is documented in a 120‑page Standard Operating Procedure (SOP) manual that is reviewed semi‑annually.
Facility Layout and Patient Flow
The 180‑square‑metre space is divided into six zones:
- Reception and waiting area (35 sqm): Seats 12 patients, equipped with a ticketing kiosk that scans QR codes from online bookings and prints a numbered queue slip. A large digital screen displays wait times, and free WiFi keeps the wait comfortable.
- Phlebotomy and sample collection bay (15 sqm): Two dedicated chairs with privacy curtains. A centrifuge and barcode printer ensure that samples for the lab are processed within three minutes of draw.
- Laboratory (30 sqm): Temperature‑controlled to 22 °C with a backup generator‑fed air conditioner. The haematology and chemistry analysers sit on anti‑vibration benches, and a Class II biosafety cabinet handles microbiology plating.
- X‑ray and CT suite (40 sqm with lead‑lined walls): The DR room and the CT scanner share a common control console. The layout was approved by the Radiation Protection Institute and includes a separate changing cubicle and a shielded waiting area for accompanying persons.
- Ultrasound room (15 sqm): Dimmable lighting and a ceiling‑mounted monitor for patient comfort.
- Administrative and staff area (45 sqm): Houses the server rack, finance desk, manager’s office, and a staff lounge with lockers.
The patient journey is linear: reception → vitals (nurse) → sample collection → imaging (if ordered) → discharge. Because the phlebotomy station and imaging suites are neighbours, a patient can complete a blood draw and an ultrasound in a single rooming event, reducing footsteps and cross‑contamination risk. The average visit time for a routine lab‑only patient is 25 minutes from door to door; a combined lab‑plus‑ultrasound visit averages 55 minutes.
Clinical Workflows and Turnaround Times
The laboratory operates in a “stat‑immediate” mode: all samples are designated as urgent unless a patient specifically requests batched processing for a lower fee. The haematology analyser completes a FBC in two minutes; the chemistry panel runs a 12‑test profile in eight minutes. The limiting factor is the manual review of abnormal results. The SOP mandates that any result outside the 95% reference interval is flagged for a technologist to examine the raw data, perform a repeat measurement if necessary, and consult the supervising clinical pathologist (Funmi Ncube) before release. This step typically adds 30 minutes, which is why the lab guarantees the result within four hours, not instantly.
The imaging workflow is similarly optimised. A chest X‑ray takes 15 minutes from the patient entering the room to the image appearing on the PACS. Avery Singh or the second radiographer performs a primary read within 20 minutes, and the images are simultaneously uploaded to the teleradiology server for oversight on complex musculoskeletal and CT cases. The teleradiology partner has a service‑level agreement of 8 hours for routine CT reports and 2 hours for “stat” reads, although the average turnaround in the pilot phase was 5.5 hours. By keeping the first‑line read in‑house, the centre can deliver preliminary results to the referring doctor within an hour for most X‑rays.
Equipment Maintenance and Consumable Management
All major equipment is covered by annual maintenance contracts with the local distributors, at a fixed cost of GHS 36,000 per year (included in the GHS 36,000 professional fees line in Year 1). The contracts guarantee a technician on site within four hours of a breakdown call. A dry‑run generator test is performed every Saturday morning to ensure the backup power system (15 kVA diesel generator) can supply the full load for at least 12 hours—crucial given Accra’s periodic “dumsor” power outages.
Reagents and consumables are sourced from three approved suppliers: Letap Pharmaceuticals for routine chemistry, MedLab Ghana for haematology reagents, and Intra‑Health Ghana for microbiology media. The finance team, under Sam Patel, maintains a minimum safety stock of 14 days’ supply for the 20 highest‑volume reagents, tracked by the LIS module that auto‑generates purchase orders when stock falls below the re‑order threshold. This system avoids stock‑outs while keeping inventory carrying costs at exactly the level baked into the COGS calculation. The initial inventory purchase of GHS 80,000, covered in the startup budget, is sufficient for the first two months of operation, after which consumable spend aligns exactly with the 25%‑of‑revenue COGS metric.
Quality Management and Accreditation Pathway
The quality management system is modelled on ISO 15189:2022. Three pillars hold it up:
- Internal quality control (IQC): Commercial control materials (normal and abnormal) are run every morning on every analyser. A Levy‑Jennings chart is maintained electronically; a 2‑2S rule triggers a root‑cause analysis and retest.
- External quality assessment (EQA): The lab is enrolled in the OneWorld Accuracy programme, an international EQA provider that sends six blinded samples every quarter. Scores below 90% prompt a mandatory corrective action meeting.
- Pre‑analytical and post‑analytical controls: All specimen rejection criteria (haemolysis, lipaemia, insufficient volume) are embedded in the LIS, and the system prevents a rejected specimen from proceeding. A monthly audit of 100 randomly selected reports checks that the correct patient name, gender, and reference ranges are attached.
Avery Singh has extended this rigour to the imaging division with a phantom‑based QA protocol for the CT scanner (daily water phantom check) and a quarterly physicist calibration. The plan is to achieve full ISO 15189 accreditation by the end of Year 2, which will position Precision Health Diagnostics as the only lab in East Legon holding that credential—a powerful differentiator for medico‑legal and insurance referrals.
Licensing, Health, Safety and Environment
The centre complies with Ghana’s Health Facilities Regulatory Agency Act, the Environmental Protection Agency’s liquid‑waste discharge permit, and the Radiation Protection Institute’s ionizing‑radiation regulations. Sharps and biohazardous waste are collected daily by a certified medical‑waste disposal company (Jekora Ventures). A spill‑response kit is mounted on the lab wall, and all staff complete an annual blood‑borne pathogen safety drill. The radiation safety officer (Avery Singh) wears a personal dosimeter that is read monthly; no cumulative dose has ever approached the 20 mSv annual limit.
Management & Organization
The founding team of five brings together clinical mastery, healthcare operations experience, financial discipline, and marketing creativity. Because the centre’s success depends on a seamless union of lab and imaging, the organisational chart ensures single‑stream accountability: the Managing Director has dotted‑line oversight of both clinical and administrative halves, while daily technical supervision is devolved to the lab and radiology leads.
Funmi Ncube — Managing Director and Clinical Lead
Dr. Funmi Ncube (MD, Laboratory Medicine, University of Ghana) is the majority shareholder and the driving clinical force behind Precision Health Diagnostics. Over 15 years, she progressed from junior laboratory physician to Head of Pathology at a 120‑bed private hospital in Tema, where she was responsible for a department that grew from 200 to 1,200 tests per day. She redesigned the specimen reception workflow, introduced barcode tracking, and reduced the critical‑value reporting time from 90 minutes to 25 minutes. Her clinical credentials, combined with her deep network in Ghana’s medical community, are the business’s strongest asset. She will spend 70% of her time on the laboratory floor during the first two quarters, personally reviewing every abnormal result and coaching the technologists, before transitioning to a business‑development role focused on corporate contracts and payer negotiations.
Morgan Kim — Director of Operations
Morgan Kim holds an MBA in Healthcare Management from the Ghana Institute of Management and Public Administration (GIMPA). His most recent role was turnaround manager for a chain of two pharmacy outlets in Accra, where he standardised inventory ordering, retrained counter staff, and cut average patient wait times from 18 to 11 minutes, a 40% reduction. At Precision Health Diagnostics, Morgan owns the end‑to‑end patient experience—from the moment an appointment is booked to the moment a report is dispatched. He will negotiate supplier contracts, manage the LIS/RIS deployment, and chair the weekly operations huddle that reviews turnaround‑time KPIs against the 4‑hour pledge.
Avery Singh — Chief Radiographer & Radiation Safety Officer
Avery Singh brings 10 years of hands‑on CT, MRI, and ultrasound experience, earned at the Lister Hospital and at a private imaging centre in Tema. He holds a Diploma in Radiography from the College of Radiographers (UK) and is licensed by the Allied Health Professions Council of Ghana. Avery will personally perform all CT scans and the more complex ultrasound studies, train the second radiographer, and run the weekly QA phantom checks. His authority as radiation safety officer gives the regulatory bodies a single point of contact, simplifying inspections.
Sam Patel — Head of Finance
Sam Patel is a Chartered Accountant and a member of the Institute of Chartered Accountants Ghana (ICA Ghana). For eight years he served as Financial Controller of a multi‑specialty clinic in Accra that operated on a GHS 6,000,000 annual budget. There, he built a cost‑per‑test model that tracked the exact margin of each laboratory service, leading to a repricing exercise that lifted overall gross margins by 12 percentage points—experience that he is replicating at Precision Health Diagnostics. Sam will oversee payroll, supplier payments, receivables from corporate clients, and the monthly board report.
Drew Martinez — Marketing Manager
Drew Martinez’s career sits at the intersection of digital advertising and healthcare. After an agency career managing campaigns for a dental group that lifted new patient registrations by 200% in six months, he joined the startup ecosystem to build in‑house marketing functions. Drew’s remit covers the website, SEO, Google and social media ads, the corporate pitch deck, and the community activation programme. His key performance indicators are cost‑per‑booking and monthly new‑patient volume, measured daily against budget.
Professional Advisors and Support
The company will retain a law firm (AB & David) for regulatory compliance and contract review, an external auditing firm (PKF) for annual statutory audits, and a part‑time IT consultant who visits weekly to patch the server and perform a backup integrity test. The board’s independent non‑executive director will be selected from a shortlist of retired senior officials from the Ghana Health Service, providing strategic guidance and facilitating introductions at the highest levels of the public system.
Financial Plan
The financial model is built on bottom‑up patient volume projections, a detailed cost‑per‑test analysis, and conservative assumptions about revenue growth and cost inflation. All figures are in Ghana Cedi (GHS) and are drawn directly from the validated five‑year forecast. The model demonstrates that the business is profitable from its first month of operation, achieves break‑even within Year 1, and generates net cash every year thereafter.
Key Assumptions
- Revenue driver: Patient visits start at 800 in Month 1 and climb to 1,300 by Month 12, mirrored in an annual Year 1 volume of 12,600 visits and total revenue of GHS 2,520,000. The weighted average revenue per visit of GHS 200 is derived from the real service menu: a typical walk‑in patient purchases a FBC (GHS 80) and a lipid profile (GHS 120), while corporate packages lift the average.
- Cost of sales: Direct consumables—reagents, phlebotomy supplies, X‑ray films (minimal with DR), contrast media, and specimen transport bags—are pegged at exactly 25% of revenue, giving a steady gross margin of 75% across all five years.
- Operating expenses: Salaries, rent, utilities, marketing, insurance, professional fees, and administration total GHS 720,000 in Year 1, escalating at an average of 8% per annum for salaries and inflation‑linked increases for other line items. Depreciation is straight‑line over five years on the GHS 1,380,000 of depreciable assets, yielding GHS 276,000 each year.
- Financing: The GHS 1,300,000 term loan carries an interest rate of 15% per annum on the reducing balance, with annual principal repayments of GHS 260,000 starting in Year 1.
Projected Profit and Loss (Year 1 – Year 3)
| Category | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Sales | GHS 2,520,000 | GHS 3,000,060 | GHS 3,883,278 |
| Direct Cost of Sales (COGS) | 630,000 | 750,015 | 970,819 |
| Total Cost of Sales | 630,000 | 750,015 | 970,819 |
| Gross Margin | 1,890,000 | 2,250,045 | 2,912,458 |
| Gross Margin % | 75.0% | 75.0% | 75.0% |
| Salaries and Wages | 360,000 | 388,800 | 419,904 |
| Rent and Utilities | 204,000 | 220,320 | 237,946 |
| Marketing and Sales | 60,000 | 64,800 | 69,984 |
| Insurance | 36,000 | 38,880 | 41,990 |
| Professional Fees | 36,000 | 38,880 | 41,990 |
| Administration | 24,000 | 25,920 | 27,994 |
| Total Operating Expenses | 720,000 | 777,600 | 839,808 |
| EBITDA | 1,170,000 | 1,472,445 | 2,072,650 |
| Depreciation | 276,000 | 276,000 | 276,000 |
| EBIT | 894,000 | 1,196,445 | 1,796,650 |
| Interest Expense | 195,000 | 156,000 | 117,000 |
| Earnings Before Tax (EBT) | 699,000 | 1,040,445 | 1,679,650 |
| Tax (25%) | 174,750 | 260,111 | 419,913 |
| Net Income | 524,250 | 780,334 | 1,259,738 |
| Net Margin % | 20.8% | 26.0% | 32.4% |
The expansion in net margin from 20.8% to 32.4% over the first three years reflects the operating leverage inherent in a fixed‑cost‑heavy diagnostic business: as revenue grows, the fixed portion of salaries, rent, and equipment maintenance is spread over a larger base, while the COGS percentage remains constant.
Projected Cash Flow (Year 1 – Year 3)
| Category | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Cash from Operations | |||
| Cash Sales (Revenue) | 2,520,000 | 3,000,060 | 3,883,278 |
| Cash from Receivables | 0 | 0 | 0 |
| Subtotal Cash from Operations | 2,520,000 | 3,000,060 | 3,883,278 |
| Additional Cash Received | |||
| New Long‑term Liabilities (Loan) | 1,300,000 | 0 | 0 |
| New Investment Received (Equity) | 900,000 | 0 | 0 |
| Subtotal Additional Cash Received | 2,200,000 | 0 | 0 |
| Total Cash Inflow | 4,720,000 | 3,000,060 | 3,883,278 |
| Expenditures from Operations | |||
| Cash Spending (COGS + OpEx excl. deprn) | (1,350,000) | (1,527,615) | (1,810,627) |
| Interest Paid | (195,000) | (156,000) | (117,000) |
| Tax Paid | (174,750) | (260,111) | (419,913) |
| Subtotal Expenditures from Operations | (1,719,750) | (1,943,726) | (2,347,540) |
| Additional Cash Spent | |||
| Purchase of Long‑term Assets (Capex) | (1,380,000) | 0 | 0 |
| Loan Principal Repayment | (260,000) | (260,000) | (260,000) |
| Subtotal Additional Cash Spent | (1,640,000) | (260,000) | (260,000) |
| Total Cash Outflow | (3,359,750) | (2,203,726) | (2,607,540) |
| Net Cash Flow | 1,234,250 | 772,331 | 1,231,577 |
| Ending Cash Balance | 1,234,250 | 2,006,581 | 3,238,158 |
The strong cash conversion—Year 1 net income of GHS 524,250 converts to an operating cash flow (before capex and financing) of GHS 674,250—is driven by the almost‑zero receivables cycle. All services are paid at the point of sale, so cash flows track revenue closely. The loan repayment schedule is front‑loaded but manageable, with the Debt Service Coverage Ratio (DSCR) lifting from 2.57 in Year 1 to 5.50 in Year 3, offering substantial headroom.
Projected Balance Sheet (Year 1 – Year 3)
| Category | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Assets | |||
| Cash | 1,234,250 | 2,006,581 | 3,238,158 |
| Inventory and Other Current Assets | 126,000 | 150,003 | 194,164 |
| Total Current Assets | 1,360,250 | 2,156,584 | 3,432,322 |
| Property, Plant & Equipment (Gross) | 1,380,000 | 1,380,000 | 1,380,000 |
| Accumulated Depreciation | (276,000) | (552,000) | (828,000) |
| Net PP&E | 1,104,000 | 828,000 | 552,000 |
| Total Assets | 2,464,250 | 2,984,584 | 3,984,322 |
| Liabilities and Equity | |||
| Long‑term Debt (incl. current portion) | 1,040,000 | 780,000 | 520,000 |
| Total Liabilities | 1,040,000 | 780,000 | 520,000 |
| Share Capital | 900,000 | 900,000 | 900,000 |
| Retained Earnings | 524,250 | 1,304,584 | 2,564,322 |
| Total Equity | 1,424,250 | 2,204,584 | 3,464,322 |
| Total Liabilities & Equity | 2,464,250 | 2,984,584 | 3,984,322 |
The balance sheet underscores financial health: by Year 3, equity represents 87% of total capital, and the business holds GHS 3,238,158 in cash, enough to fund the planned Year 3 satellite collection point in Osu without additional borrowing. The “Inventory and Other Current Assets” line captures reagent stock and modest prepayments, ensuring the total assets always balance to the penny with liabilities and equity, as per the double‑entry model.
Break‑Even Analysis
| Item | Year 1 Value |
|---|---|
| Fixed Costs (OpEx + Depreciation + Interest) | GHS 1,191,000 |
| Gross Margin | 75% |
| Break‑Even Revenue | GHS 1,588,000 |
| Actual Year 1 Revenue | GHS 2,520,000 |
| Break‑Even Achieved | Within Month 1 |
The business reaches break‑even revenue early in its first quarter. Because month‑one revenue is projected at GHS 160,000 (800 visits × GHS 200) and the monthly fixed‑cost run rate is GHS 99,250 (GHS 1,191,000 ÷ 12), the centre generates a positive net contribution from its first day of operation. Even under a stress scenario where patient volume falls 30% below target, the company would still cover all fixed costs and service its debt by Month 4.
Funding Request
Precision Health Diagnostics Ltd. seeks GHS 1,300,000 in the form of a five‑year term loan from a local commercial bank. This amount, together with GHS 900,000 in founders’ equity, comprises the total capital requirement of GHS 2,200,000. The loan will be partially secured against the medical equipment assets, which have a combined insured value of GHS 1,380,000, providing a collateral coverage ratio of 1.06× the loan principal.
Use of Funds
| Allocation | Amount (GHS) |
|---|---|
| Equipment and IT (analysers, DR, CT, ultrasound, PACS/RIS/LIS) | 1,200,000 |
| Furniture and Renovation (fit‑out, branded interiors) | 180,000 |
| Registration and Licensing | 20,000 |
| Initial Inventory (reagents, consumables) | 80,000 |
| Pre‑Launch Marketing | 30,000 |
| Working Capital Reserve (six months of OpEx + COGS during ramp) | 668,000 |
| Contingency (3% buffer) | 22,000 |
| Total | 2,200,000 |
The working capital reserve of GHS 668,000 is carefully calculated to cover the first six months of fixed operating costs (GHS 360,000) and the variable COGS that will be incurred during the patient‑volume ramp‑up phase (GHS 278,000), ensuring the business never faces a cash squeeze. The contingency of GHS 22,000 absorbs any unexpected registration delays or minor equipment commissioning costs.
Repayment and Security
The 15%‑per‑annum term loan will be repaid in equal annual principal instalments of GHS 260,000. Interest is calculated on the declining balance, resulting in a total debt‑service cost of GHS 455,000 in Year 1 and decreasing thereafter. The bank’s security package will include a debenture over the company’s fixed assets, an assignment of the key‑man life insurance policy on Funmi Ncube, and a personal guarantee from the shareholders up to 30% of the loan value. The Debt Service Coverage Ratio, which measures EBITDA against scheduled principal and interest, starts at 2.57 and improves every year, reaching 13.04 by Year 5. This ratio comfortably exceeds the banks’ typical minimum covenant of 1.5×, giving the lender high confidence.
Appendix / Supporting Information
The following supporting documents are available to prospective investors and lenders under a non‑disclosure agreement:
- Certificate of Incorporation and Registrar General’s Department filing
- HeFRA site‑inspection report and provisional licence correspondence
- Radiation Protection Institute type‑approval letters for the X‑ray and CT equipment
- Curriculum vitae of the five founding team members
- Leasing agreement for the East Legon premises (Lagos Avenue)
- Equipment quotations and pro‑forma invoices from the three main vendors
- Detailed 120‑page Standard Operating Procedure manual
- ISO 15189 pre‑accreditation roadmap and timeline
- Sample patient‑report and referring‑physician portal screen mock‑ups
- Competitor pricing survey conducted March 2025 across 10 private facilities in Accra
- Letters of intent from three corporate HR managers expressing interest in annual wellness packages
- Independent market size memorandum prepared by Ashesi University’s Centre for Health Systems Research
- Full five‑year financial model in Excel format, including sensitivity analysis at 80% and 120% of base‑case volumes
All material facts, financial figures, and legal status representations contained in this business plan are true and accurate as of the date stated on the cover letter. The company commits to updating investors with quarterly performance reports and an annual audited set of financial statements, maintaining the transparency that has governed the preparation of this document.